摘要
目的:本研究旨在调查膳食益生元摄入量与阿尔茨海默病 (AD) 风险之间的关系。 方法:这项纵向研究包括 1,837 名老年人(≥65 岁)参与者,他们参加了一项基于多种族社区的队列研究,他们在基线时没有痴呆,并从食物频率问卷中提供了饮食信息。果聚糖(最著名的益生元之一)的每日总摄入量是根据食用频率和每份 8 种食物的果聚糖含量计算得出的。使用 Cox 比例风险模型检查每日果聚糖摄入量与 AD 风险的关联,并根据队列招募波、年龄、性别、种族/民族、教育、每日热量摄入和 APOE 基因型进行调整。通过在 Cox 模型中包含交互项以及分层分析,测试了种族/民族、APOE 基因型和性别的影响修正。 结果:在 1,837 名参与者(1,263 名女性 [69%];平均 [SD] 年龄 = 76 [6.3] 岁)中,平均随访 7.5 年(13736 人-年)期间发生了 391 例 AD 病例。每多摄入一克果聚糖,AD 风险降低 24%((95% CI)=0.60-0.97;P =0.03)。对吸烟、饮酒和合并症指数的额外调整并没有显着改变结果。尽管分层分析表明,果聚糖摄入与西班牙裔的 AD 风险降低显着相关,但与非西班牙裔黑人或白人无关。 结论:较高的膳食果聚糖摄入量与老年人临床阿尔茨海默病风险降低有关。
关键词: 膳食益生元消耗、阿尔茨海默病、痴呆症、APOE 基因型、中枢神经系统 (CNS)、帕金森病、多发性硬化症。
Current Alzheimer Research
Title:Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population
Volume: 18 Issue: 12
关键词: 膳食益生元消耗、阿尔茨海默病、痴呆症、APOE 基因型、中枢神经系统 (CNS)、帕金森病、多发性硬化症。
摘要:
Objective: This study aimed to investigate the association between dietary prebiotic intake and risk for Alzheimer’s disease (AD).
Methods: This longitudinal study includes 1,837 elderly (≥65 years) participants of a multi-ethnic community-based cohort study who were dementia-free at baseline and had provided dietary information from food frequency questionnaires. Total daily intake of fructan, one of the best-known prebiotics, was calculated based on consumption frequency and fructan content per serving of 8 food items. The associations of daily fructan intake with AD risk were examined using a Cox proportional hazards model, adjusted for cohort recruitment wave, age, gender, race/ethnicity, education, daily caloric intake, and APOE genotype. Effect modification by race/ethnicity, APOE genotype, and gender was tested by including an interaction term into the Cox models, as well as by stratified analyses.
Results: Among 1,837 participants (1,263 women [69%]; mean [SD] age = 76 [6.3] years), there were 391 incident AD cases during a mean follow-up of 7.5 years (13736 person-years). Each additional gram of fructan intake was associated with 24% lower risk for AD ((95% CI)=0.60-0.97; P =0.03). Additional adjusting for smoking, alcohol consumption, and comorbidity index did not change results materially. The associations were not modified by race/ethnicity, gender, and APOE genotype, although stratified analyses showed that fructan intake was significantly associated with reduced AD risk in Hispanics but not in non-Hispanic Blacks or Whites.
Conclusion: Higher dietary fructan intake is associated with a reduced risk of clinical Alzheimer’s disease among older adults.
Export Options
About this article
Cite this article as:
Association of Dietary Prebiotic Consumption with Reduced Risk of Alzheimer’s Disease in a Multiethnic Population, Current Alzheimer Research 2021; 18 (12) . https://dx.doi.org/10.2174/1567205019666211222115142
DOI https://dx.doi.org/10.2174/1567205019666211222115142 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anti-atherosclerotic Effects of Spice-Derived Phytochemicals
Current Medicinal Chemistry Apoptosis in Anthracycline Cardiomyopathy
Current Pediatric Reviews Microalgal Fatty Acids and Their Implication in Health and Disease
Mini-Reviews in Medicinal Chemistry The Shift in the “Paradigm” of the Pharmacology of Hypertension
Current Topics in Medicinal Chemistry Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Levosimendan for Heart-Operated Patients: What is the State of the Art?
Recent Patents on Cardiovascular Drug Discovery The Spatial QRS-T Angle: Implications in Clinical Practice
Current Cardiology Reviews Your Father and Grandfather’s Atrial Fibrillation: A Review of the Genetics of the Most Common Pathologic Cardiac Dysrhythmia
Current Genomics Serum Endocan, Neuron-Specific Enolase and Ischemia-Modified Albumin Levels in Newborns with Partial Blood Exchange Transfusion
Combinatorial Chemistry & High Throughput Screening HSP60 as a Drug Target
Current Pharmaceutical Design Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design
Current Medicinal Chemistry Is the Vascular System a Main Target for Thyroid Hormones? From Molecular and Biochemical Findings to Clinical Perspectives
Current Vascular Pharmacology Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Calcium Sensitizers in Cardiac Surgery: Who, When, How and Why?
Current Vascular Pharmacology Therapy Against Ischemic Injury
Current Pharmaceutical Design Contemporary Risk Assessment and Cardiovascular Outcomes in Peripheral Arterial Disease
Cardiovascular & Hematological Disorders-Drug Targets Diabetes and Vascular Disease: Is It All About Glycemia?
Current Pharmaceutical Design Efficacy and Cardiovascular Safety of DPP-4 Inhibitors
Current Drug Safety The Influence of Obese Insulin-Resistance on the Outcome of the Ischemia/Reperfusion Insult to the Heart
Current Medicinal Chemistry Chemical Nature and Reaction Mechanisms of the Molybdenum Cofactor of Xanthine Oxidoreductase
Current Pharmaceutical Design